Kari Furu

Summary

Affiliation: Norwegian Institute of Public Health
Country: Norway

Publications

  1. pmc Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study
    Ingeborg Hartz
    Faculty of Health Studies, Hedmark University College, Kirkeveieen 47, 2418 Elverum, Norway
    BMC Clin Pharmacol 7:14. 2007
  2. pmc High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database
    Kari Furu
    Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, Oslo, Norway
    J Clin Epidemiol 64:878-84. 2011
  3. doi The Nordic countries as a cohort for pharmacoepidemiological research
    Kari Furu
    Norwegian Institute of Public Health, Oslo and Institute of Pharmacy, University of Tromsø, Tromsø, Norway
    Basic Clin Pharmacol Toxicol 106:86-94. 2010
  4. ncbi Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis
    Kari Furu
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, PO Box 4404, Nydalen, 0403 Oslo, Norway
    Eur J Clin Pharmacol 63:693-8. 2007
  5. ncbi [Self-reported medical drug use among 15-16 year-old adolescents in Norway]
    Kari Furu
    Avdeling for legemiddelepidemiologi, Nasjonalt folkehelseinstitutt, Postboks 4404 Nydalen, 0403 Oslo
    Tidsskr Nor Laegeforen 125:2759-61. 2005
  6. doi Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Svetlana Skurtveit
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Eur J Pain 13:949-53. 2009
  7. ncbi Psychotropic drug use among persons with mental distress symptoms: a population-based study in Norway
    Anne M Hausken
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Scand J Public Health 35:356-64. 2007
  8. doi Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors
    Anne M Hausken
    Division of Epidemiology, Norwegian Institute of Public Health, PO Box 4404, Nydalen, 0403 Oslo, Norway
    Eur J Clin Pharmacol 65:295-301. 2009
  9. doi Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
    Helene M Devold
    Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
    Pharmacoepidemiol Drug Saf 21:297-304. 2012
  10. doi Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study
    Marte Handal
    Dept of Pharmacoepidemiology, Norwegian Institute of Public Health, P O Box 4404 Nydalen, 0403, Oslo, Norway
    Eur J Clin Pharmacol 67:953-60. 2011

Detail Information

Publications47

  1. pmc Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study
    Ingeborg Hartz
    Faculty of Health Studies, Hedmark University College, Kirkeveieen 47, 2418 Elverum, Norway
    BMC Clin Pharmacol 7:14. 2007
    ..Our objective was to explore how differences in prevalences of use, dosing characteristics, choice of statin and continuity of therapy in individual patients adds new information to previous results...
  2. pmc High validity of mother-reported use of antiasthmatics among children: a comparison with a population-based prescription database
    Kari Furu
    Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, Oslo, Norway
    J Clin Epidemiol 64:878-84. 2011
    ....
  3. doi The Nordic countries as a cohort for pharmacoepidemiological research
    Kari Furu
    Norwegian Institute of Public Health, Oslo and Institute of Pharmacy, University of Tromsø, Tromsø, Norway
    Basic Clin Pharmacol Toxicol 106:86-94. 2010
    ..This research may assist in resolving safety issues of international interest, thus minimizing the risk of either over-reacting on possible signals or underestimating drug safety issues...
  4. ncbi Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis
    Kari Furu
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, PO Box 4404, Nydalen, 0403 Oslo, Norway
    Eur J Clin Pharmacol 63:693-8. 2007
    ..The aim of this study was to assess the prevalence of dispensed anti-asthmatic medications as a proxy of asthma among children and adolescents aged 0-19 years in Norway...
  5. ncbi [Self-reported medical drug use among 15-16 year-old adolescents in Norway]
    Kari Furu
    Avdeling for legemiddelepidemiologi, Nasjonalt folkehelseinstitutt, Postboks 4404 Nydalen, 0403 Oslo
    Tidsskr Nor Laegeforen 125:2759-61. 2005
    ..Little information is available about Norwegian adolescents' use of medical drugs...
  6. doi Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?
    Svetlana Skurtveit
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Eur J Pain 13:949-53. 2009
    ..9 (1.6-2.3). So far, it is questionable whether the introduction of LD-TD-BUP actually has stabilised opioids consumption or whether it has complicated and increased the consumption of potentially addictive drugs...
  7. ncbi Psychotropic drug use among persons with mental distress symptoms: a population-based study in Norway
    Anne M Hausken
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Scand J Public Health 35:356-64. 2007
    ..To explore psychotropic drug use in the general population and in particular among non-institutionalized persons with mental distress symptoms...
  8. doi Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors
    Anne M Hausken
    Division of Epidemiology, Norwegian Institute of Public Health, PO Box 4404, Nydalen, 0403 Oslo, Norway
    Eur J Clin Pharmacol 65:295-301. 2009
    ..Drugs prescribed for the treatment of insomnia can be either benzodiazepine hypnotics or the newer z-hypnotics, zopiclone and zolpidem. This paper explores possible explanations for the choice made...
  9. doi Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway
    Helene M Devold
    Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
    Pharmacoepidemiol Drug Saf 21:297-304. 2012
    ..To examine whether socioeconomic factors influence adherence to alendronate drug treatment among incident users in Norway during 2005-2009...
  10. doi Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study
    Marte Handal
    Dept of Pharmacoepidemiology, Norwegian Institute of Public Health, P O Box 4404 Nydalen, 0403, Oslo, Norway
    Eur J Clin Pharmacol 67:953-60. 2011
    ..The aim of the study was to describe the use of prescribed opioid analgesics for noncancer pain and the degree of possible concurrent co-medication with benzodiazepines to women in Norway before, during, and after pregnancy...
  11. pmc Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway
    Anders Engeland
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, Oslo, Norway
    Eur J Epidemiol 26:157-63. 2011
    ..If the increase in frequency of GDM observed in MBRN in recent years is real, a further increase in diabetic women can be expected...
  12. doi Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study
    Kirsten K Viktil
    Diakonhjemmet Hospital Pharmacy, Oslo and Department of Pharmacotherapeutics, Diakonhjemmet Hospital Pharmacy, Faculty of Medicine, University of Oslo, Oslo, Norway
    Pharmacoepidemiol Drug Saf 18:737-42. 2009
    ..Exploring the use of antirheumatic drugs in pregnant women and expectant fathers...
  13. doi Mental distress and subsequent use of anxiolytic drugs--a prospective population-based cohort study of 16,000 individuals
    Anne M Hausken
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Scand J Public Health 38:465-73. 2010
    ..To study the relationship between mental distress and later use of anxiolytic drugs, taking into account potential confounders such as lifestyle and socioeconomic factors...
  14. doi Benzodiazepines predict use of opioids--a follow-up study of 17,074 men and women
    Svetlana Skurtveit
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Pain Med 11:805-14. 2010
    ..To evaluate the effect of the use of benzodiazepines on prescription of opioids 4-7 years later in patients with noncancer pain...
  15. doi The validity of self-reported prescription medication use among adolescents varied by therapeutic class
    Svetlana Skurtveit
    Norwegian Institute of Public Health, Division of Epidemiology, P O Box 4404 Nydalen, N 0403 Oslo, Norway
    J Clin Epidemiol 61:714-7. 2008
    ..The objective of this study was to estimate the sensitivity and specificity of self-reported use of medication using a prescription database as reference standard...
  16. doi Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway
    Helene M Devold
    Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
    Eur J Clin Pharmacol 66:299-306. 2010
    ..To assess 1-year prevalence, incidence rates and minimum refill of anti-osteoporosis drug use in Norway by age, gender and place of residence during 2004-2007...
  17. doi A prospective study of asthma and subsequent use of hypnotics in young adults
    Oystein Karlstad
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Pharmacoepidemiol Drug Saf 20:370-7. 2011
    ..To examine whether young adults with asthma are at higher risk of initiating hypnotic use...
  18. doi Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations
    Svetlana Skurtveit
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, PO Box 4404 Nydalen, N 0403 Oslo, Norway
    J Clin Epidemiol 66:964-72. 2013
    ..To assess the impact of exposure misclassification on risk associations when using prescription databases as the source for drug exposure in pregnancy by applying results from a validation analysis of exposure classification...
  19. pmc Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases
    Anders Engeland
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Br J Clin Pharmacol 75:1134-41. 2013
    ..We aimed to explore associations between drugs dispensed to the father prior to conception and pregnancy outcomes, such as pre-term birth, perinatal mortality, foetal growth retardation and birth defects...
  20. doi The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults--a population-based cohort study
    Tomas Log
    Institute of Pharmacy, University of Tromsø, Tromsø, Norway
    Pharmacoepidemiol Drug Saf 20:90-8. 2011
    ..The use of prescribed opioids for chronic non-cancer pain is increasing in many countries. It is, therefore, important to investigate predictors for repeated use of opioids in young non-cancer patients...
  21. pmc Switching statins in Norway after new reimbursement policy: a nationwide prescription study
    Solveig Sakshaug
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Br J Clin Pharmacol 64:476-81. 2007
    ..To assess the changes in prescribing of statins in Norway after implementation of the new reimbursement regulations for statins in June 2005...
  22. pmc Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education
    Randi Selmer
    Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Br J Clin Pharmacol 67:355-62. 2009
    ..To study the influence of patients' education and cardiovascular risk factors on the probability of statin treatment...
  23. doi Benzodiazepine use in all alcohol consumers predicts use of opioids in patients 20 years later--a follow-up study of 13,390 men and women aged 40-42 years
    Svetlana Skurtveit
    Division of Epidemiology, Norwegian Institute of Public Health, P O Box 4404, Nydalen, 0403 Oslo, Norway
    Pharmacoepidemiol Drug Saf 17:926-933. 2008
    ..To evaluate the effect of the consumption of benzodiazepines at age 40-42 years on prescription of opioids later in life...
  24. doi Prescription drug use among pregnant women in opioid Maintenance Treatment
    Ingunn Olea Lund
    SERAF Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway
    Addiction 108:367-76. 2013
    ..This study describes the use of prescribed drugs among women in opioid maintenance treatment (OMT) prior to, and during, pregnancy...
  25. doi The association between prescribed opioid use for mothers and children: a record-linkage study
    Tomas Log
    Department of Pharmacy, University of Tromsø, 9037 Tromsø, Norway
    Eur J Clin Pharmacol 69:111-8. 2013
    ..It is therefore important to examine factors associated with such repeated use. The aim of this study was to investigate the association between the maternal use of prescription opioids and their use by offspring of these mothers...
  26. doi Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study
    Oystein Karlstad
    Norwegian Institute of Public Health, Oslo, Norway
    Eur J Clin Pharmacol 66:399-406. 2010
    ....
  27. pmc Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006
    Anders Engeland
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Br J Clin Pharmacol 65:653-60. 2008
    ..In this registry-based study, we examined more than 100,000 Norwegian pregnancies and described the drug prescription pattern of both fathers and mothers around conception and during pregnancy (mothers)...
  28. doi Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005-2009
    Milada Mahic
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Pharmacoepidemiol Drug Saf 20:457-63. 2011
    ..Examining the prevalence, incidence and persistence of use of etanercept and adalimumab in Norway during 2005-2009...
  29. doi Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study
    Svetlana Skurtveit
    Department of Pharmacoepidemiology, Norwegian Institute of Public Health, and Norwegian Centre for Addiction Research, University of Oslo, Norway
    Ann Epidemiol 20:890-7. 2010
    ..The aim of this study was to evaluate prospectively smoking dependence as a predictor of repeated use of prescribed opioids in non-cancer patients...
  30. doi The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study
    Jørgen G Bramness
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, NO 0881 Oslo, Norway
    J Affect Disord 117:208-11. 2009
    ..Our study aimed to explore how common the use of lithium, valproate and lamotrigine in psychiatric conditions in children and adolescents in Norway and to describe concomitant use of other psychotropic drugs...
  31. doi Comorbidities in an asthma population 8-29 years old: a study from the Norwegian Prescription Database
    Øystein Karlstad
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Pharmacoepidemiol Drug Saf 21:1045-52. 2012
    ..To examine the occurrence of chronic diseases and antimicrobial treatment in an asthma population 8-29 years old, compared with the general population...
  32. ncbi [Changes in the sale and use of flunitrazepam in Norway after 1999]
    Jørgen G Bramness
    Avdeling for legemiddelepidemiologi, Divisjon for epidemiologi, Nasjonalt folkehelseinstitutt, Postboks 4404 Nydalen, 0403 Oslo
    Tidsskr Nor Laegeforen 126:589-90. 2006
    ..On 1 August 2004 the manufacturer of the Rohypnol brand withdrew it from the Norwegian market. How did these two events influence the sales and use of drugs containing flunitrazepam?..
  33. pmc Carisoprodol use and abuse in Norway: a pharmacoepidemiological study
    Jørgen G Bramness
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Br J Clin Pharmacol 64:210-8. 2007
    ..Carisoprodol was developed to create a drug with less potential for abuse than meprobamate. However, case reports have established carisoprodol as a drug of abuse. This paper explores the extent of potential abuse of this drug in Norway...
  34. ncbi Why do sales of lipid-lowering drugs vary between counties in Norway? Evidence from the OPPHED Health Study 2000-2001
    Ingeborg Hartz
    Department of Pharmacy, University of Tromsø, Norway
    Scand J Prim Health Care 24:115-21. 2006
    ....
  35. doi To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use?
    Svetlana Skurtveit
    Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Pain 152:1555-61. 2011
    ..In a cohort of new opioid users who started treatment with weak opioids, only 0.3% and 0.08% developed prescription patterns indicating persistent opioid use and problematic opioid use, respectively...
  36. doi Validation of disease registration in pregnant women in the Medical Birth Registry of Norway
    Anders Engeland
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, N 0403, Oslo, Norway
    Acta Obstet Gynecol Scand 88:1083-9. 2009
    ..The registration of asthma overall was 51%, but considerably higher for more serious asthma. Except for diabetes type 1, the medical disease diagnoses in the MBRN should be dealt with carefully...
  37. pmc Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy
    Helene M Devold
    Department of Pharmacoepidemiology, Norwegian Institute of Public Health, P b 4404 Nydalen, Oslo, Norway
    Br J Clin Pharmacol 67:234-41. 2009
    ..Co-medication with interacting drugs increases the risk of statin-induced muscular side-effects. Simvastatin exhibits particularly high interaction potential due to substantial metabolism via cytochrome P450 3A4 (CYP3A4)...
  38. ncbi [Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?]
    Jørgen G Bramness
    Avdeling for legemiddelepidemiologi, Divisjon for epidemiologi, Nasjonalt folkehelseinstitutt, Postboks 4404 Nydalen, 0403 Oslo
    Tidsskr Nor Laegeforen 127:2653-5. 2007
    ..The newly established Norwegian Prescription Database was used to investigate whether these warnings have had an effect...
  39. doi Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in norway
    Oystein Karlstad
    Department of Pharmacoepidemiology, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
    Eur Addict Res 20:59-65. 2014
    ..2013 S. Karger AG, Basel. ..
  40. pmc Risk of fetal death after pandemic influenza virus infection or vaccination
    Siri E Håberg
    Norwegian Institute of Public Health, Oslo, Norway
    N Engl J Med 368:333-40. 2013
    ..This concern was complicated by questions about vaccine safety in pregnant women that were raised by anecdotal reports of fetal deaths after vaccination...
  41. ncbi The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults-a population-based cohort study
    Tomas Log
    Institute of Pharmacy, University of Tromsø, Tromsø, Norway
    Pharmacoepidemiol Drug Saf 20:90-8. 2011
    ..The use of prescribed opioids for chronic non-cancer pain is increasing in many countries. It is, therefore, important to investigate predictors for repeated use of opioids in young non-cancer patients...
  42. ncbi Determinants of control of high blood pressure. The Oslo Health Study 2000-2001
    Serena Tonstad
    Department of Preventive Cardiology, Preventive Medicine Clinic, Ulleval University Hospital, Oslo, Norway
    Blood Press 13:343-9. 2004
    ..To examine determinants of control of high blood pressure in Oslo, Norway...
  43. ncbi Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies
    Oystein Karlstad
    Norwegian Institute of Public Health, P O Box 4404 Nydalen, N 0403 Oslo, Norway
    Curr Drug Saf 8:333-48. 2013
    ..An association of insulin use and risk of cancer has been reported but evidence is conflicting and methodological issues have been identified...
  44. doi Generic substitution: micro evidence from register data in Norway
    Dag Morten Dalen
    BI Norwegian School of Management, Oslo, Norway
    Eur J Health Econ 12:49-59. 2011
    ..In markets with more recent entry of generic drugs, brand-name loyalty proves to be much stronger, giving less explanatory power to our demand model...
  45. ncbi Use of psychotropic drugs in an urban adolescent population: the impact of health-related variables, lifestyle and sociodemographic factors--The Oslo Health Study 2000-2001
    Svetlana Skurtveit
    Division of Epidemiology, Norwegian Institute of Public Health, Nydalen, Oslo, Norway
    Pharmacoepidemiol Drug Saf 14:277-83. 2005
    ..The aims of the study were to examine use of psychotropic drugs among 15-16 years old adolescents and to study the association between use of drugs and health-related, lifestyle and sociodemographic factors...
  46. pmc Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Baseline data from The Prescription Peer Academic Detailing (Rx-PAD) study
    Mette Brekke
    Section for General Practice, Department of General Practice and Community Health, University of Oslo, Norway
    Scand J Prim Health Care 26:80-5. 2008
    ..To assess Norwegian general practitioners' (GPs') level of potentially harmful drug prescribing for elderly patients...
  47. ncbi [Prescribing of stimulants for ADHD in Nordland County]
    Harald Asheim
    Poliklinikk, BUPA, Avdeling for psykiatri, Nordlandssykehuset
    Tidsskr Nor Laegeforen 127:2360-2. 2007
    ..Stimulants are an important part of the treatment of ADHD. The present study examines the prescribing of stimulants for ADHD in Nordland County in 2004 compared to data from 1999...